Nurse Practitioner Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Roxanne Radich

Nurse Practitioner Appleton, WI Nurse Practitioner

NPI 1639165962 CMS profile 10447627

3916 N Intertech Ct, Appleton, WI 54913

Open in the dashboard

General payments

$53,766

142 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Roxanne Radich of Appleton, WI is reported in the CMS Open Payments database as having received $53,766 across 142 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $29 1
2023 General $71 3
2022 General $11,999 33
2021 General $41,668 105

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Roxanne Radich
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Roxanne Radich were reported at $0. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Roxanne Radich Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $41,668 $135 $40–$426 $132
2022 $11,999 $152 $48–$470 $149
2023 $71 $166 $54–$529 $160
2024 $29 $173 $55–$556 $164
2025 $0 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. Novo Nordisk Inc $25,304 45 payments
  2. Dexcom, Inc. $23,624 50 payments
  3. Boehringer Ingelheim Pharmaceuticals, Inc. $1,763 6 payments
  4. RGH Enterprises, Inc. $1,640 3 payments
  5. Lilly USA, LLC $543 2 payments
  6. Medtronic, Inc. $391 21 payments
  7. Sanofi-Aventis U.S. LLC $346 7 payments
  8. Mannkind Corporation $50 1 payment
  9. Abbott Laboratories $33 2 payments
  10. AstraZeneca Pharmaceuticals LP $28 2 payments
  11. Other $44 3 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $45,708 52 payments
  2. Food and Beverage $2,773 62 payments
  3. Travel and Lodging $2,542 22 payments
  4. Consulting Fee $1,982 4 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $728 1 payment
  6. Education $32 1 payment
Products named General payments · program years 2021–2024
  1. DEXCOM G6 TRANSMITTER Endocrinology $22,770 45 payments
  2. RYBELSUS $19,757 33 payments
  3. Ozempic $5,517 12 payments
  4. JARDIANCE Diabetes $1,763 6 payments
  5. Dexcom G6 Transmitter Endocrinology $854 5 payments
  6. JARDIANCE Diabetes $525 1 payment
  7. SOLIQUA 100/33 $248 4 payments
  8. INTELLIS ADAPTIVESTIM $135 7 payments
  9. MINIMED 770G $109 5 payments
  10. Minimed 670G System $57 4 payments
  11. Other $304 17 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

142 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record